2m 2m 2m 2m 2m 2m 2m
Hims&Hers Hlth-A (HIMS)
NYSE
$34.22+$0.68 (+2.02%)
Price as of Jun 23, 2026 12:01 PM EDT- $7.5BMarket Cap
- -20.10%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Hims&Hers Hlth-A (HIMS)
$34.22+$0.68 (+2.02%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.3B +59.00% | 1.5B +69.33% | 872.0M +65.49% | 526.9M +93.81% | |
Cost of Revenue | 614.3M +102.47% | 303.4M +93.17% | 157.1M +32.88% | 118.2M +75.40% | |
Gross Profit | 1.7B +47.76% | 1.2B +64.09% | 714.9M +74.92% | 408.7M +99.87% | |
Sales and Marketing Expense | 919.3M +35.42% | 678.8M +52.06% | 446.4M +63.78% | 272.6M +100.58% | |
Research and Development Expense | -149.3M +89.42% | -78.8M +63.43% | -48.2M +64.95% | -29.2M N/A | |
Depreciation and Amortization Expense | 54.5M +218.95% | 17.1M +79.59% | 9.5M +27.31% | 7.5M +83.41% | |
Total Operating Expenses | 1.6B +46.48% | 1.1B +49.28% | 744.4M +55.92% | 477.4M +49.41% | |
Operating Profit | 105.6M +70.61% | 61.9M +310.18% | -29.5M -57.13% | -68.7M -40.29% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 18.3M +86.69% | 9.8M +24.44% | 7.9M +163.79% | 3.0M -29.64% | |
Income before Taxes | 123.9M +72.81% | 71.7M +432.44% | -21.6M -67.17% | -65.7M -40.69% | |
Income Taxes | -4.4M -91.83% | -54.3M -2,850.73% | 2.0M +6,470.97% | -31,000 -99.01% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 128.4M +1.85% | 126.0M +635.28% | -23.5M -64.15% | -65.7M -38.99% | |
Net Income from Continuing Operations Applicable to Common | 123.9M +72.81% | 71.7M +432.44% | -21.6M -67.17% | -65.7M -40.69% | |
Basic EPS and Net Income | 0.57 -1.72% | 0.58 +627.27% | -0.11 -65.62% | -0.32 -44.83% | |
Diluted EPS and Net Income | 0.51 -3.77% | 0.53 +581.82% | -0.11 -65.62% | -0.32 -44.83% | |
Basic Weighted Average Shares | 225.0M +4.18% | 215.9M +3.15% | 209.3M +2.36% | 204.5M +9.49% | |
Diluted Weighted Average Shares | 258.2M +9.05% | 236.8M +13.12% | 209.3M +2.36% | 204.5M +9.49% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 228.6M +3.64% | 220.6M +128.20% | 96.7M +106.67% | 46.8M -34.84% | |
Short-Term Investments | 348.9M +337.92% | 79.7M -35.92% | 124.3M -6.42% | 132.9M -24.30% | |
Cash and Cash Equivalents and Short-Term Investments | 577.5M +92.34% | 300.3M +35.87% | 221.0M +23.02% | 179.6M -27.36% | |
Total Current Assets | 767.6M +93.93% | 395.8M +49.34% | 265.1M +22.37% | 216.6M -19.75% | |
Accumulated Depreciation | 52.6M +114.66% | 24.5M +100.09% | 12.2M N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | 3.0M +36.36% | |
Total Long-Term Assets | 29.7M +20,090.48% | 147,000 +61.54% | 91,000 -99.19% | 11.2M +41.43% | |
Total Assets | 2.2B +204.54% | 707.5M +60.37% | 441.2M +20.43% | 366.3M -12.90% | |
Income Taxes Payable | 28.9M N/A | N/A N/A | 2.0M +108.62% | 963,000 +0.94% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 404.4M +82.70% | 221.4M +150.22% | 88.5M +84.54% | 47.9M -39.48% | |
Total Long-Term Debt | 972.6M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 11.7M N/A | 0 -100.00% | 22,000 -37.14% | 35,000 -94.44% | |
Total Liabilities | 1.6B +599.14% | 230.8M +137.58% | 97.2M +77.94% | 54.6M -36.49% | |
Retained Earnings | -113.8M -53.01% | -242.1M -34.23% | -368.2M +6.83% | -344.6M +23.54% | |
Total Stockholders Equity | 540.9M +13.47% | 476.7M +38.57% | 344.0M +10.36% | 311.7M -6.84% | |
Total Shares Outstanding | 218.9M -0.89% | 220.8M +3.45% | 213.5M +2.42% | 208.4M +1.78% | |
Cash Flow | |||||
Cash from Operating Activities | 300.0M +19.48% | 251.1M +241.69% | 73.5M +376.97% | -26.5M -22.90% | |
Capital Expenditures | 242.6M +359.47% | 52.8M N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -1.0B +5,280.92% | -19.0M +57.34% | -12.1M -134.89% | 34.7M +122.20% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 729.6M +776.55% | -107.8M +839.83% | -11.5M -65.36% | -33.1M -114.09% | |
Financials Ratio | |||||
Gross Margin | 73.84% -7.07% | 79.45% -3.09% | 81.99% +5.70% | 77.57% +3.13% | |
Operating Margin | 4.50% +7.30% | 4.19% +224.13% | -3.38% -74.09% | -13.04% -69.19% | |
Return on Assets | 8.97% -59.13% | 21.94% +476.29% | -5.83% -65.06% | -16.69% -51.45% | |
Return on Equity | 25.23% -17.86% | 30.71% +527.69% | -7.18% -64.66% | -20.32% -67.95% | |
Revenue Growth | 59.00% -14.90% | 69.33% +5.85% | 65.49% -30.18% | 93.81% N/A | |
Current Ratio | 1.90 +6.15% | 1.79 -40.32% | 3.00 -33.69% | 4.52 +32.61% | |
Cash Ratio | 0.57 -43.27% | 1.00 -8.80% | 1.09 +11.99% | 0.98 +7.67% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow